Cargando…
Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children
Background: In 2010, Greenland introduced the 13-valent pneumococcal conjugate vaccine (Prevnar 13®– PCV-13) in the childhood immunisation program. The authors aimed to evaluate the impact of PCV-13 on nasopharyngeal carriage of bacteria frequently associated with respiratory infections in children....
Autores principales: | Navne, Johan Emdal, Koch, Anders, Slotved, Hans-Christian, Andersson, Mikael, Melbye, Mads, Ladefoged, Karin, Børresen, Malene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497538/ https://www.ncbi.nlm.nih.gov/pubmed/28467237 http://dx.doi.org/10.1080/22423982.2017.1309504 |
Ejemplares similares
-
Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
por: Nikolova, Kristiana Alexandrova, et al.
Publicado: (2021) -
The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
por: Adamu, Aishatu L., et al.
Publicado: (2023) -
Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study
por: Hammitt, Laura L, et al.
Publicado: (2019) -
Direct Effect of 10-Valent Conjugate Pneumococcal Vaccination on Pneumococcal Carriage in Children Brazil
por: Andrade, Ana Lucia, et al.
Publicado: (2014) -
Living conditions, quality of life, adherence and treatment outcome in Greenlandic HIV patients
por: Ladefoged, Karin, et al.
Publicado: (2012)